Bay Area Biotech
Life Sciences

Innate Pharma And The Role Of The Innate Immune System In Cancer Immunotherapy

By Joseph Juan, Dimitre Simeonov, Katherine Woronowicz, Henok Eyob, Ph.D., Armen Mekhjian, and Evan Markegard

Overview of Cancer Immunotherapy

The buzz may be all about cancer immunotherapy this year, but this area of research has roots in experiments over 120 years old. A doctor named William Coley was the first to guide the power of the immune system to target his patients' inoperable tumors. He injected his patients' tumors with streptococcus bacteria in order to trigger a fierce immune response and subsequent regression of the targeted tumor.

Thanks to the fact that we no longer inject tumors with bacteria, interest in the field of immunotherapy is booming. Citigroup analyst Andrew Baum estimates that by 2023, immunotherapy will grow to a ...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details